Loading...
XASXSHL
Market cap8.16bUSD
Dec 20, Last price  
27.17AUD
1D
-1.20%
1Q
3.35%
Jan 2017
26.96%
Name

Sonic Healthcare Ltd

Chart & Performance

D1W1MN
XASX:SHL chart
P/E
25.53
P/S
1.51
EPS
1.06
Div Yield, %
3.83%
Shrs. gr., 5y
1.16%
Rev. gr., 5y
7.14%
Revenues
8.93b
+12.17%
1,359,902,0001,645,184,0001,877,682,0002,365,014,0002,995,605,0002,972,613,0003,082,883,0003,322,532,0003,484,073,0003,913,475,0004,200,524,9995,017,720,0005,122,143,0005,541,371,0006,133,671,0006,562,590,0009,127,759,0009,306,543,0007,964,853,0008,934,198,000
Net income
511m
-25.39%
-11,944,000172,029,000198,072,000245,116,000171,360,000293,225,000294,535,000315,996,000334,998,000384,984,000347,698,000451,374,000427,773,000475,606,000549,725,000527,749,0001,315,040,0001,460,566,000684,984,000511,094,000
CFO
1.07b
-27.16%
218,315,000247,208,000267,935,000331,885,000429,952,000429,497,000409,019,000486,758,000459,459,000556,358,000512,083,999707,708,000736,365,000767,920,000847,308,0001,360,298,0002,042,836,0002,225,821,0001,471,033,0001,071,512,000
Dividend
Sep 04, 20240.63 AUD/sh
Earnings
Feb 18, 2025

Profile

Sonic Healthcare Limited offers medical diagnostic services in Australia. The company provides laboratory medicine/pathology; diagnostic imaging/radiology, including magnetic resonance imaging, computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry; and primary care medical services comprising general practice services, occupational health services, remote health services, community and home nursing services, primary care research programs, health assessment technologies, clinical trials, and chronic disease management programs to clinicians, hospitals, community health services, and their patients. It also offers administrative services and facilities to medical practitioners. The company operates in Australia, New Zealand, the United Kingdom, the United States, Germany, Switzerland, Belgium, and Ireland. Sonic Healthcare Limited was incorporated in 1934 and is headquartered in Sydney, Australia.
IPO date
Sep 25, 1934
Employees
41,000
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑062015‑06
Income
Revenues
8,934,198
12.17%
7,964,853
-14.42%
9,306,543
1.96%
Cost of revenue
8,117,748
9,936,389
9,779,335
Unusual Expense (Income)
NOPBT
816,450
(1,971,536)
(472,792)
NOPBT Margin
9.14%
Operating Taxes
186,847
223,257
561,739
Tax Rate
22.89%
NOPAT
629,603
(2,194,793)
(1,034,531)
Net income
511,094
-25.39%
684,984
-53.10%
1,460,566
11.07%
Dividends
(499,413)
(480,353)
(455,397)
Dividend yield
3.98%
2.86%
2.86%
Proceeds from repurchase of equity
194,411
(46,668)
(253,733)
BB yield
-1.55%
0.28%
1.59%
Debt
Debt current
661,030
347,204
341,858
Long-term debt
5,381,816
3,833,917
2,670,879
Deferred revenue
1,080,228
1,093,945
Other long-term liabilities
212,229
1,007,084
104,446
Net debt
5,199,497
3,169,589
2,049,327
Cash flow
Cash from operating activities
1,071,512
1,471,033
2,225,821
CAPEX
(470,612)
(497,013)
(378,589)
Cash from investing activities
(1,805,443)
(580,041)
(989,180)
Cash from financing activities
592,406
(911,511)
(1,349,294)
FCF
326,147
(2,392,681)
(1,106,471)
Balance
Cash
645,001
797,994
779,997
Long term investments
198,348
213,538
183,413
Excess cash
396,639
613,289
498,083
Stockholders' equity
8,081,711
7,921,862
7,434,076
Invested Capital
12,406,083
10,537,470
9,673,015
ROIC
5.49%
ROCE
6.20%
EV
Common stock shares outstanding
476,989
472,444
482,880
Price
26.30
-26.06%
35.57
7.76%
33.01
-14.04%
Market cap
12,544,798
-25.35%
16,804,816
5.43%
15,939,869
-13.78%
EV
17,901,797
20,159,763
18,144,230
EBITDA
1,593,755
(1,268,608)
202,625
EV/EBITDA
11.23
89.55
Interest
151,347
87,025
79,819
Interest/NOPBT
18.54%